Clinical Trials Logo
  1. Home
  2. Cognitive Disorders
  3. NCT00743405

Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects

Cognitive Disorders Clinical Trial

Official title:
Single-blind, Randomised, Placebo Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects

Clinical Trial Summary

This is a First Time in Human Study to assess the safety, tolerability and pharmacokinetics of single doses of GSK1034702 in healthy subjects. It will be a single-blind, randomized, placebo-controlled, single oral dose, dose-rising, cross-over study in healthy male and female (of non-child bearing potential) subjects. Subjects will be randomized into cohorts of 10 subjects and cohorts will be recruited until the pre-defined safety or PK stopping limits are reached. Each subject will receive placebo and up to 4 doses of GSK1034702 in a randomized sequence on 5 separate study occasions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00743405
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 1
Start date May 2, 2008
Completion date December 15, 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Recruiting NCT02777060 - Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures N/A
Completed NCT02342041 - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects Phase 1
Recruiting NCT01659593 - Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients N/A
Completed NCT01561820 - Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study N/A
Completed NCT05373394 - Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
Completed NCT04860414 - Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials. N/A
Completed NCT02324153 - Ramelteon in the Prevention of Post-operative Delirium Phase 2
Completed NCT00458094 - Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses N/A
Completed NCT05486195 - A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect Phase 1
Not yet recruiting NCT03866018 - Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders N/A
Recruiting NCT02876536 - Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients N/A
Completed NCT02321475 - EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
Completed NCT01881646 - Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery Phase 4
Recruiting NCT05888961 - Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials N/A
Completed NCT01983384 - Anesthetic Depth and Postoperative Delirium Trial - 2 N/A
Completed NCT02575482 - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects Phase 1
Completed NCT00937846 - Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study Phase 1
Completed NCT01772095 - ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE N/A
Completed NCT06078332 - Remote Cognitive Multidomain Assessment in People With Cognitive Disorders